ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,375 | 12,499 | 7,940 | 4,369 | 28,747 |
| Depreciation Amortization | 6,900 | 4,789 | 2,742 | 1,327 | 3,878 |
| Income taxes - deferred | -1,877 | 55 | 413 | 294 | -14,459 |
| Accounts receivable | -4,635 | -4,348 | -1,583 | -74 | -4,784 |
| Other Working Capital | -13,821 | -12,633 | -13,754 | -7,121 | -115 |
| Other Operating Activity | 15,322 | 12,200 | 6,568 | 2,325 | 8,766 |
| Operating Cash Flow | $17,264 | $12,562 | $2,326 | $1,120 | $22,033 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,183 | -1,078 | -310 | -112 | -1,120 |
| Purchase Sale Intangibles | -30,500 | -30,500 | -4,500 | -4,500 | -34,634 |
| Other Investing Activity | -30,500 | -30,500 | -4,500 | -4,500 | -34,634 |
| Investing Cash Flow | $-32,683 | $-31,578 | $-4,810 | $-4,612 | $-35,754 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 138,243 |
| Common Stock Issued | 819 | 771 | 244 | 9 | 48,249 |
| Common Stock Repurchased | -113 | -113 | -113 | N/A | N/A |
| Other Financing Activity | 360 | 234 | 47 | 9 | -14,839 |
| Financing Cash Flow | $1,066 | $892 | $178 | $18 | $171,653 |
| Beginning Cash Position | 169,037 | 169,037 | 169,037 | 169,037 | 11,105 |
| End Cash Position | 154,684 | 150,913 | 166,731 | 165,563 | 169,037 |
| Net Cash Flow | $-14,353 | $-18,124 | $-2,306 | $-3,474 | $157,932 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,264 | 12,562 | 2,326 | 1,120 | 22,033 |
| Capital Expenditure | -2,183 | -1,078 | -310 | -112 | -1,120 |
| Free Cash Flow | 15,081 | 11,484 | 2,016 | 1,008 | 20,913 |